Supplemental figure 10. Kaplan-Meier survival analysis demonstrating improved PFS in p53abn EC patients with endometrioid tumors compared to non-endometrioid tumors (carcinosarcoma, clear cell, serous and other) in the total cohort.
No takes yet. Share an insight, caveat, or question.
Jamieson et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: